Webinar: IN FOCUS: Biomarker Commercialization Guide – Go-to-Market Phases/27.09.2021
The BIC Biomarker Commercialization project consortium is organizing a free webinar on how to commercialize your biomarker discovery, the last webinar of a series focusing on biomarker commercialization process.
Focus of this webinar is on the go-to-market phases of the commercialization process.
This webinar introduces the participants to the different biomarker commercialization tools that aim to guide the user through the process of commercializing a biomarker invention.
Webinar programme:
14:00-14:15 CEST Introduction to the BIC Biomarker Commercialization Tools
Valerie Daussin Laurent, Team Leader Business Development, Aalborg University Hospital, Project Leader BIC BRIDGE consortium
14:15-14:30 CEST How SMEs can Best Utilize the Go-to-Market Phases of the Biomarker Commercialization Guide (in connection with the IVDR Roadmap)
Teppo Laaksonen, Network Manager, Turku Science Park Ltd
14:30-14:45 CEST Tuleap Project Management Tool for Biomarker Development Projects
Ewa Zdunczyk, Project Manager at Wroclaw Technology Park
14:45-15:00 CEST BIC Educational Toolbox
Monica Recabarren, Project Leader, Aalborg University Hospital
15:00-15:15 CEST Q&A
Moderator: Teppo Laaksonen, Network Manager, Turku Science Park Ltd
Please register HERE
The Biomarker Commercialization (BIC BRIDGE) consortium is developing a Biomarker Commercialization Toolset, designed to support, step-by-step, both academic researchers and SMEs when developing a biomarker-based invention to a commercial product. The BIC toolset includes a Biomarker Commercialization Guide, which covers technical, clinical, commercial and regulatory aspects, a Best Practices Handbook based on experiences from TTOs in the field, a Review Tool for TTOs, a Toolset for the regulatory process, an Educational Toolbox, as well as a Project Management Template. The toolset will be available for free in autumn 2021. The BIC BRIDGE project is funded by Interreg Baltic Sea Region Programme. More information on the project: https://biomarker.nu/